Polaris Biologics (Polyreactivity / SEC / Tm)

Polaris Hub biologics benchmarks: polyreactivity, SEC-SMAC, Tm + titer.

Composite

79.0

Experimental validation

Prospective

Stages

Developmental Candidate

Modalities

biologic-mab

Task types

developability

Size

tasks: 6
antibodies: 2,000

License

Polaris Community

First release

2024-04

Last updated

2025-03

Official site

→ project page

Leaderboard

→ leaderboard

Dataset

→ dataset

Code / GitHub

→ repository

HuggingFace

→ HF

Paper

Polaris biologics method comparison · W, o, g, n, u, m, , C, , e, t, , a, l, . · 2024 · paper · doi:N/A · 15 citations

Flags

none

Experts

Cas Wognum

Groups

Valence Labs (Recursion), Recursion Pharmaceuticals

Hosted by

Polaris Hub, ScienceAIBench, Drug Discovery Benchmarks (DDB)

Related benchmarks

Polaris ADMET

Rubric (7-criterion)

rigor

coverage

maintenance

adoption

quality

accessibility

industry_relevance

Notes

Industry-donated; growing.

← Back to all benchmarks

Compare:

Open comparison →